Sonomax Technologies, Esterline Racal Acoustics agree to establish R&D License Agreement

NewsGuard 100/100 Score

Sonomax Technologies Inc. (SHH:TSX Venture) is pleased to announce that it has signed another in a series of Term Sheets that it intends to enter into in 2010. The agreement is with Racal Acoustics Ltd., a component of Esterline Technologies Corp. (NYSE:ESL). Under the terms of the agreement the parties have agreed to work toward establishing an R&D License Agreement by July 15th, 2010, the object of which will be to evaluate then develop the use of Sonomax V4 earpiece technology ("Sonomax Outside") as the centerpiece in the development of a suite of military hearing protection and communication applications.

Esterline Racal Acoustics is a world leading supplier of high quality, state-of-the-art military audio and data products designed to operate in the most severe battle environments. From secure audio and data intercommunication/networking systems to rugged noise-canceling handsets and headsets, ERA is on the front lines of battlefield communication. Esterline Racal Acoustics has a long history of design, development and manufacture of audio ancillary equipment for the world's military markets. Based in London, UK, the company employs approximately 180 staff.

Esterline Racal Acoustics products are designed to protect hearing and enhance communication in high and medium noise environments, such as aircraft, tracked and wheeled vehicles as well as for dismounted soldiers. The product range includes noise attenuating, lightweight and In-The-Ear headsets, handsets, microphones, field communications systems and avionics equipment.

Source:

SONOMAX TECHNOLOGIES INC.

Posted in:

Tags: , ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Teen brains with depression show heightened sensitivity to parental criticism